StockGlow

Telix Pharmaceuticals Limited (TLPPF)

Develops radioactive drugs that target and treat cancers like prostate and kidney cancer.

$10.41+0.00%Healthcare
Compare TLPPF with
StockGlow Score
80
Bullish
BearishBullish
1 year ago-23.2%

The outlook

TLPPF is trading above both its 50- and 200-day moving averages, positioning it in the middle-to-upper portion of its 52-week range. Analyst coverage appears thin based on available data. The current price sits neutral relative to longer-term trend support levels.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range57% of the way from its 52-week low to high
Market cap
$3.53B
52-wk high
$13.75
52-wk low
$5.91
50-day avg
$10.19
200-day avg
$9.10
Trailing P/E
—

Similar stocks

IVBXFInnovent Biologics, Inc.$10.86-15.16%ZLDPFZealand Pharma A/S$45.50+1.08%UCBJYUCB SA$142.43+1.98%WXIBFWuXi Biologics (Cayman) Inc.$4.60+0.00%PTCHFPureTech Health plc$1.80+12.71%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy